Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...

Sanofi: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated regu ...

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis

Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis PERSEUS phase 3 study in primary progressive multiple sclerosis did not meet its primary endpoint in delaying time to ...

Clinicians now have powerful new tools to diagnose multiple sclerosis earlier

The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that ...

The Bull Case For Johnson & Johnson (JNJ) Could Change Following New Multiple Myeloma Breakthrough Data

Johnson & Johnson recently reported Phase 3 data showing that its TECVAYLI plus DARZALEX FASPRO combination cut the risk of ...

Cerence: A Conversational AI Automotive Specialist With Multiple Tailwinds Going For It

Cerence (CRNC) is poised for growth with strong FCF yield, surging backlog, and AI innovation. Read here for a detailed ...

A Closer Look at 3M's Options Market Dynamics

Looking at options history for 3M (NYSE: MMM) we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish ...
Medical Xpress

Genetic clues: Can depression risk predict MS progression?

Researchers in the Rady Faculty of Health Sciences are exploring whether a person's genetic risk for depression can help predict how multiple sclerosis (MS) progresses. "A lot of people with MS end up ...
The Business Journals

This Bay Area founder's personal mission to track multiple sclerosis has backing of Roche and more

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The family of the company's co ...
Medscape

Can Fluid Biomarkers Predict MS Progression?

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Cross: Your story ...
USA Today

MSNBC is becoming MS NOW. What to know about the change and how to watch.

It's a new dawn for MSNBC, which is being rebranded and will now be known as MS NOW. The transition comes as the channel breaks off from its current parent company, Comcast NBCUniversal, and moves to ...
Los Angeles Times

Why MS NOW? What the MSNBC name change means for viewers

This is read by an automated voice. Please report any issues or inconsistencies here. MSNBC rebrands to MS NOW as NBCUniversal spins the cable network into new company Versant, separating from NBC ...